A family of multiple endocrine neoplasia type 2A with the RET proto-oncogene mutation in codon 618 (Cys→Arg)

Atsunori Nakao, Yoshio Naomoto, Masafumi Kataoka, Minoru Haisa, Kazuhiko Kataoka, Shinya Saito, Toshiyoshi Fujiwara, Tomoki Yamatsuji, Kaoru Shigemitsu, Tatsuo Umeoka, Hiroshi Isozaki, Hitoyasu Futami, Ken Yamaguchi, Noriaki Tanaka

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Multiple endocrine neoplasia type 2 (MEN-2) is a hereditary syndrome characterized by medullary thyroid carcinoma (MTC), pheochromocytoma and hyperplasia or adenoma of the parathyroid gland with hyperparathyroidism. Recent genetic studies have identified the presence of germline missense mutations in the RET proto-oncogene in almost 100% of MEN-2 patients. We report here three generations of one MEN-2 family with rare missense mutation at codon 618 (Cys→Arg) of the RET proto-oncogene. The first patient was surgically treated at the age of 63 years but died of bone metastasis. His two children (29-year-old daughter and 25-year-old son) were treated surgically for MTC and neck lymph node metastasis. Germline mutations of the RET proto-oncogene of these three MTC patients and two children of the 29-year-old daughter (9-year-old female and 7-year-old male) were examined. Three MTC patients and the 9-year-old female possessed the mutation. The phenotype of the family with this rare point mutation of the RET proto-oncogene is reported.

Original languageEnglish
Pages (from-to)157-161
Number of pages5
JournalJapanese Journal of Clinical Oncology
Volume31
Issue number4
Publication statusPublished - 2001

Fingerprint

Multiple Endocrine Neoplasia Type 2a
Proto-Oncogenes
Codon
Nuclear Family
Mutation
Germ-Line Mutation
Missense Mutation
Neoplasm Metastasis
Parathyroid Glands
Hyperparathyroidism
Pheochromocytoma
Point Mutation
Adenoma
Hyperplasia
Neck
Lymph Nodes
Phenotype
Bone and Bones
Medullary Thyroid cancer

Keywords

  • Medullary thyroid carcinoma
  • Multiple endocrine neoplasia type 2A
  • Prophylactic surgery
  • RET proto-oncogene

ASJC Scopus subject areas

  • Oncology

Cite this

A family of multiple endocrine neoplasia type 2A with the RET proto-oncogene mutation in codon 618 (Cys→Arg). / Nakao, Atsunori; Naomoto, Yoshio; Kataoka, Masafumi; Haisa, Minoru; Kataoka, Kazuhiko; Saito, Shinya; Fujiwara, Toshiyoshi; Yamatsuji, Tomoki; Shigemitsu, Kaoru; Umeoka, Tatsuo; Isozaki, Hiroshi; Futami, Hitoyasu; Yamaguchi, Ken; Tanaka, Noriaki.

In: Japanese Journal of Clinical Oncology, Vol. 31, No. 4, 2001, p. 157-161.

Research output: Contribution to journalArticle

Nakao, A, Naomoto, Y, Kataoka, M, Haisa, M, Kataoka, K, Saito, S, Fujiwara, T, Yamatsuji, T, Shigemitsu, K, Umeoka, T, Isozaki, H, Futami, H, Yamaguchi, K & Tanaka, N 2001, 'A family of multiple endocrine neoplasia type 2A with the RET proto-oncogene mutation in codon 618 (Cys→Arg)', Japanese Journal of Clinical Oncology, vol. 31, no. 4, pp. 157-161.
Nakao, Atsunori ; Naomoto, Yoshio ; Kataoka, Masafumi ; Haisa, Minoru ; Kataoka, Kazuhiko ; Saito, Shinya ; Fujiwara, Toshiyoshi ; Yamatsuji, Tomoki ; Shigemitsu, Kaoru ; Umeoka, Tatsuo ; Isozaki, Hiroshi ; Futami, Hitoyasu ; Yamaguchi, Ken ; Tanaka, Noriaki. / A family of multiple endocrine neoplasia type 2A with the RET proto-oncogene mutation in codon 618 (Cys→Arg). In: Japanese Journal of Clinical Oncology. 2001 ; Vol. 31, No. 4. pp. 157-161.
@article{697f6b333c4b4d97beb385130ef37c5e,
title = "A family of multiple endocrine neoplasia type 2A with the RET proto-oncogene mutation in codon 618 (Cys→Arg)",
abstract = "Multiple endocrine neoplasia type 2 (MEN-2) is a hereditary syndrome characterized by medullary thyroid carcinoma (MTC), pheochromocytoma and hyperplasia or adenoma of the parathyroid gland with hyperparathyroidism. Recent genetic studies have identified the presence of germline missense mutations in the RET proto-oncogene in almost 100{\%} of MEN-2 patients. We report here three generations of one MEN-2 family with rare missense mutation at codon 618 (Cys→Arg) of the RET proto-oncogene. The first patient was surgically treated at the age of 63 years but died of bone metastasis. His two children (29-year-old daughter and 25-year-old son) were treated surgically for MTC and neck lymph node metastasis. Germline mutations of the RET proto-oncogene of these three MTC patients and two children of the 29-year-old daughter (9-year-old female and 7-year-old male) were examined. Three MTC patients and the 9-year-old female possessed the mutation. The phenotype of the family with this rare point mutation of the RET proto-oncogene is reported.",
keywords = "Medullary thyroid carcinoma, Multiple endocrine neoplasia type 2A, Prophylactic surgery, RET proto-oncogene",
author = "Atsunori Nakao and Yoshio Naomoto and Masafumi Kataoka and Minoru Haisa and Kazuhiko Kataoka and Shinya Saito and Toshiyoshi Fujiwara and Tomoki Yamatsuji and Kaoru Shigemitsu and Tatsuo Umeoka and Hiroshi Isozaki and Hitoyasu Futami and Ken Yamaguchi and Noriaki Tanaka",
year = "2001",
language = "English",
volume = "31",
pages = "157--161",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - A family of multiple endocrine neoplasia type 2A with the RET proto-oncogene mutation in codon 618 (Cys→Arg)

AU - Nakao, Atsunori

AU - Naomoto, Yoshio

AU - Kataoka, Masafumi

AU - Haisa, Minoru

AU - Kataoka, Kazuhiko

AU - Saito, Shinya

AU - Fujiwara, Toshiyoshi

AU - Yamatsuji, Tomoki

AU - Shigemitsu, Kaoru

AU - Umeoka, Tatsuo

AU - Isozaki, Hiroshi

AU - Futami, Hitoyasu

AU - Yamaguchi, Ken

AU - Tanaka, Noriaki

PY - 2001

Y1 - 2001

N2 - Multiple endocrine neoplasia type 2 (MEN-2) is a hereditary syndrome characterized by medullary thyroid carcinoma (MTC), pheochromocytoma and hyperplasia or adenoma of the parathyroid gland with hyperparathyroidism. Recent genetic studies have identified the presence of germline missense mutations in the RET proto-oncogene in almost 100% of MEN-2 patients. We report here three generations of one MEN-2 family with rare missense mutation at codon 618 (Cys→Arg) of the RET proto-oncogene. The first patient was surgically treated at the age of 63 years but died of bone metastasis. His two children (29-year-old daughter and 25-year-old son) were treated surgically for MTC and neck lymph node metastasis. Germline mutations of the RET proto-oncogene of these three MTC patients and two children of the 29-year-old daughter (9-year-old female and 7-year-old male) were examined. Three MTC patients and the 9-year-old female possessed the mutation. The phenotype of the family with this rare point mutation of the RET proto-oncogene is reported.

AB - Multiple endocrine neoplasia type 2 (MEN-2) is a hereditary syndrome characterized by medullary thyroid carcinoma (MTC), pheochromocytoma and hyperplasia or adenoma of the parathyroid gland with hyperparathyroidism. Recent genetic studies have identified the presence of germline missense mutations in the RET proto-oncogene in almost 100% of MEN-2 patients. We report here three generations of one MEN-2 family with rare missense mutation at codon 618 (Cys→Arg) of the RET proto-oncogene. The first patient was surgically treated at the age of 63 years but died of bone metastasis. His two children (29-year-old daughter and 25-year-old son) were treated surgically for MTC and neck lymph node metastasis. Germline mutations of the RET proto-oncogene of these three MTC patients and two children of the 29-year-old daughter (9-year-old female and 7-year-old male) were examined. Three MTC patients and the 9-year-old female possessed the mutation. The phenotype of the family with this rare point mutation of the RET proto-oncogene is reported.

KW - Medullary thyroid carcinoma

KW - Multiple endocrine neoplasia type 2A

KW - Prophylactic surgery

KW - RET proto-oncogene

UR - http://www.scopus.com/inward/record.url?scp=0034983548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034983548&partnerID=8YFLogxK

M3 - Article

C2 - 11386462

AN - SCOPUS:0034983548

VL - 31

SP - 157

EP - 161

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 4

ER -